Propanc Biopharma, Inc. (PPCB)
1.07
-0.06
(-5.31%)
USD |
NASDAQ |
Aug 26, 16:00
1.08
+0.01
(+0.93%)
After-Hours: 20:00
Propanc Biopharma Price to Book Value : 0.0952 for Aug. 26, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 26, 2026 | 0.0952 |
| August 25, 2026 | 0.1005 |
| August 24, 2026 | 0.1028 |
| August 21, 2026 | 0.0961 |
| August 20, 2026 | 0.0979 |
| August 19, 2026 | 0.1014 |
| August 18, 2026 | 0.1032 |
| August 17, 2026 | 0.1023 |
| August 14, 2026 | 0.1085 |
| August 13, 2026 | 0.1085 |
| August 12, 2026 | 0.1077 |
| August 11, 2026 | 0.1041 |
| August 10, 2026 | 0.1023 |
| August 07, 2026 | 0.1068 |
| August 06, 2026 | 0.121 |
| August 05, 2026 | 0.105 |
| August 04, 2026 | 0.0908 |
| August 03, 2026 | 0.0934 |
| July 31, 2026 | 0.0899 |
| July 30, 2026 | 0.0925 |
| July 29, 2026 | 0.0881 |
| July 28, 2026 | 0.1077 |
| July 27, 2026 | 0.1174 |
| July 24, 2026 | 0.1219 |
| July 23, 2026 | 0.129 |
| Date | Value |
|---|---|
| July 22, 2026 | 0.1281 |
| July 21, 2026 | 0.1228 |
| July 20, 2026 | 0.1228 |
| July 17, 2026 | 0.1326 |
| July 16, 2026 | 0.1415 |
| July 15, 2026 | 0.145 |
| July 14, 2026 | 0.145 |
| July 13, 2026 | 0.1424 |
| July 10, 2026 | 0.1432 |
| July 09, 2026 | 0.1584 |
| July 08, 2026 | 0.1601 |
| July 07, 2026 | 0.1619 |
| July 06, 2026 | 0.1673 |
| July 02, 2026 | 0.1575 |
| July 01, 2026 | 0.1281 |
| June 30, 2026 | 0.1335 |
| June 29, 2026 | 0.1406 |
| June 26, 2026 | 0.1308 |
| June 25, 2026 | 0.1343 |
| June 24, 2026 | 0.1326 |
| June 23, 2026 | 0.1308 |
| June 22, 2026 | 0.1317 |
| June 18, 2026 | 0.1308 |
| June 17, 2026 | 0.1521 |
| June 16, 2026 | 0.1717 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Immutep Ltd. | -- |
| CSL Ltd. | -- |
| Ceryvyn Therapeutics Ltd. | -- |
| Mesoblast Ltd. | 2.880 |
| Actinogen Medical Ltd. | -- |
Price to Book Value Related Metrics
| Price | 1.07 |
| Earnings Yield | -3.10K% |
| Market Cap | 0.9356M |